The multifaceted role of curcumin in cancer prevention and treatment. (Q34667865)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665066%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

review article

5 references

25 January 2021

8 February 2021

18 July 2021

19 July 2021

The multifaceted role of curcumin in cancer prevention and treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665066%20AND%20SRC:MED&resulttype=core&format=json

phytogenic antineoplastic agents

29 February 2020

main subject

curcumin

0 references

1 reference

25 January 2021

1 reference

8 February 2021

cell population proliferation

1 reference

18 July 2021

anti-inflammatory agent

1 reference

19 July 2021

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665066%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Muthu K Shanmugam

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665066%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Grishma Rane

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665066%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Madhu Mathi Kanchi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665066%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Frank Arfuso

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665066%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Arunachalam Chinnathambi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665066%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

M E Zayed

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665066%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Sulaiman Ali Alharbi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665066%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Benny K H Tan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665066%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Alan Prem Kumar

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665066%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

English

0 references

publication date

5 February 2015

5 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665066%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

25 January 2021

8 February 2021

18 July 2021

19 July 2021

5 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665066%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

25 January 2021

8 February 2021

18 July 2021

19 July 2021

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665066%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665066%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

2728-2769

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665066%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution

29 February 2020

copyright license

4 references

25 January 2021

8 February 2021

18 July 2021

19 July 2021

0 references

Pharmacology of Curcuma longa

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin overcomes the inhibitory effect of nitric oxide on Leishmania

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin attenuation of acute adriamycin myocardial toxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Role of curcumin in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin: the Indian solid gold

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin and cancer: an "old-age" disease with an "age-old" solution

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Inflammation and cancer: how friendly is the relationship for cancer patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Inflammation and cancer: how hot is the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Multitargeting by curcumin as revealed by molecular interaction studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Multifaceted link between cancer and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Potential pharmacological control of the NF-κB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Switching on kinases: oncogenic activation of BRAF and the PDGFR family

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

AKT/PKB signaling: navigating downstream

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Cell signaling by receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

AP-1: a double-edged sword in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Emerging roles of ATF2 and the dynamic AP1 network in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Tumour necrosis factor-alpha mediates tumour promotion via a PKC alpha- and AP-1-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Functional proteomics to dissect tyrosine kinase signalling pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Communication between the extracellular environment, cytoplasmic signalling cascades and the nuclear cell-cycle machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

AP-1 function and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin: a new cell-permeant inhibitor of the inositol 1,4,5-trisphosphate receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin inhibits neurotensin-mediated interleukin-8 production and migration of HCT116 human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Hydrogen peroxide stimulates proliferation and migration of human prostate cancer cells through activation of activator protein-1 and up-regulation of the heparin affin regulatory peptide gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Dietary turmeric modulates DMBA-induced p21ras, MAP kinases and AP-1/NF-kappaB pathway to alter cellular responses during hamster buccal pouch carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Nuclear factor-kappaB activation: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Telomerase: central regulator of all of the hallmarks of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Telomerase directly regulates NF-κB-dependent transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

NF-κB addiction and its role in cancer: ‘one size does not fit all’

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Nuclear factor-kappa B: from clone to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Chronic adipose tissue inflammation: all immune cells on the stage.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

WIP1 phosphatase is a negative regulator of NF-kappaB signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Modulation of transcription factors by curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Potential anticancer activity of turmeric (Curcuma longa).

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin, a component of golden spice: from bedside to bench and back

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha /IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Inhibition of nuclear factor-kappaB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin induces stress response, neurite outgrowth and prevent NF-kappaB activation by inhibiting the proteasome function.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Expression of angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 is highly responsive to ambient glutamine availability: role of nuclear factor-kappaB and activating protein-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Demethoxycurcumin suppresses migration and invasion of MDA-MB-231 human breast cancer cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-kappa B signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin enhances the efficacy of chemotherapy by tailoring p65NFκB-p300 cross-talk in favor of p53-p300 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin down-regulates visfatin expression and inhibits breast cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin induces cell death and restores tamoxifen sensitivity in the antiestrogen-resistant breast cancer cell lines MCF-7/LCC2 and MCF-7/LCC9.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Mechanistic evaluation of the signaling events regulating curcumin-mediated chemosensitization of breast cancer cells to 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin potentiates the antitumor effects of Bacillus Calmette-Guerin against bladder cancer through the downregulation of NF-kappaB and upregulation of TRAIL receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin, but not Prima-1, decreased tumor cell proliferation in the syngeneic murine orthotopic bladder tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin selectively induces apoptosis in cutaneous T-cell lymphoma cell lines and patients' PBMCs: potential role for STAT-3 and NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Oxidative stress induced by curcumin promotes the death of cutaneous T-cell lymphoma (HuT-78) by disrupting the function of several molecular targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin Enhances the Effect of Cisplatin in Suppression of Head and Neck Squamous Cell Carcinoma via Inhibition of IKKβ Protein of the NFκB Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Chemoprevention of head and neck squamous cell carcinoma through inhibition of NF-κB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin Dually Inhibits Both Mammalian Target of Rapamycin and Nuclear Factor-κB Pathways through a Crossed Phosphatidylinositol 3-Kinase/Akt/IκB Kinase Complex Signaling Axis in Adenoid Cystic Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

NFκB inhibitors induce cell death in glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Inhibitory effect of curcumin on oral carcinoma CAL-27 cells via suppression of Notch-1 and NF-κB signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Inhibition of nuclear factor kappa-B signaling reduces growth in medulloblastoma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Anti-carcinogenic action of curcumin by activation of antioxidant defence system and inhibition of NF-κB signalling in lymphoma-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin improves the antitumor effect of X-ray irradiation by blocking the NF-κB pathway: an in-vitro study of lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin induces the differentiation of myeloid-derived suppressor cells and inhibits their interaction with cancer cells and related tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin suppresses T cell activation by blocking Ca2+ mobilization and nuclear factor of activated T cells (NFAT) activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

The effect of the NF-kappa B inhibitors curcumin and lactacystin on myogenic differentiation of rhabdomyosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Retracted: Curcumin Potentiates Rhabdomyosarcoma Radiosensitivity by Suppressing NF-κB Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin abrogates bile-induced NF-κB activity and DNA damage in vitro and suppresses NF-κB activity whilst promoting apoptosis in vivo, suggesting chemopreventative potential in Barrett's oesophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Effects of curcumin on stem-like cells in human esophageal squamous carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Inhibition of the PI3K/AKT-NF-κB pathway with curcumin enhanced radiation-induced apoptosis in human Burkitt's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin Enhances Docetaxel-Induced Apoptosis of 8505C Anaplastic Thyroid Carcinoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

The nuclear receptor superfamily: the second decade

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Identification of novel peroxisome proliferator-activated receptor-gamma (PPARγ) agonists using molecular modeling method.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Isorhamnetin inhibits proliferation and invasion and induces apoptosis through the modulation of peroxisome proliferator-activated receptor γ activation pathway in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Targeting PPARγ Signaling Cascade for the Prevention and Treatment of Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin decreases cholangiocarcinogenesis in hamsters by suppressing inflammation-mediated molecular events related to multistep carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Inhibitory effect of curcumin on uterine leiomyoma cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Hepatoprotection via the IL-6/Stat3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Transcription factors in liver development, differentiation, and regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Molecular cloning and expression of an IL-6 signal transducer, gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Signaling mechanisms through gp130: a model of the cytokine system

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin (Diferuloylmethane) Inhibits Constitutive and IL-6-Inducible STAT3 Phosphorylation in Human Multiple Myeloma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin induces growth-arrest and apoptosis in association with the inhibition of constitutively active JAK-STAT pathway in T cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane).

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin regulates signal transducer and activator of transcription (STAT) expression in K562 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin inhibits constitutive STAT3 phosphorylation in human pancreatic cancer cell lines and downregulation of survivin/BIRC5 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Lysophosphatidic acid induces STAT3 phosphorylation and ovarian cancer cell motility: their inhibition by curcumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

An anticancer effect of curcumin mediated by down-regulating phosphatase of regenerating liver-3 expression on highly metastatic melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Dietary curcumin attenuates glioma growth in a syngeneic mouse model by inhibition of the JAK1,2/STAT3 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin: a novel Stat3 pathway inhibitor for chemoprevention of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

The Wnt signaling pathway in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Wnt/beta-catenin signaling in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

The many ways of Wnt in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin, a multi-functional chemopreventive agent, blocks growth of colon cancer cells by targeting beta-catenin-mediated transactivation and cell-cell adhesion pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

The inhibitory mechanism of curcumin and its derivative against beta-catenin/Tcf signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Natural derivatives of curcumin attenuate the Wnt/beta-catenin pathway through down-regulation of the transcriptional coactivator p300.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin interrupts the interaction between the androgen receptor and Wnt/β-catenin signaling pathway in LNCaP prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin attenuates β-catenin signaling in prostate cancer cells through activation of protein kinase D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin suppresses proliferation and invasion in non-small cell lung cancer by modulation of MTA1-mediated Wnt/β-catenin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Nrf2 the rescue: effects of the antioxidative/electrophilic response on the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

NRF2, cancer and calorie restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Role of protein kinase C delta in curcumin-induced antioxidant response element-mediated gene expression in human monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs demethylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin inhibits proliferation of breast cancer cells through Nrf2-mediated down-regulation of Fen1 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

TNF: a master switch for inflammation to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Targeting TNF for Treatment of Cancer and Autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Role of epigenetics in inflammation-associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin inhibits protease-activated receptor-2 and -4-mediated mast cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Synergistic effect of combination of phenethyl isothiocyanate and sulforaphane or curcumin and sulforaphane in the inhibition of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Gene expression profiling related to anti-inflammatory properties of curcumin in K562 leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Dietary curcumin increases antioxidant defenses in lung, ameliorates radiation-induced pulmonary fibrosis, and improves survival in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Therapeutic roles of curcumin: lessons learned from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Tumor necrosis factor alpha induces Warburg-like metabolism and is reversed by anti-inflammatory curcumin in breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Long-term effect of curcumin down-regulates expression of tumor necrosis factor-α and interleukin-6 via modulation of E26 transformation-specific protein and nuclear factor-κB transcription factors in livers of lymphoma bearing mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin regulates airway epithelial cell cytokine responses to the pollutant cadmium

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Antioxidant and anti-inflammatory properties of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin combined with turmerones, essential oil components of turmeric, abolishes inflammation-associated mouse colon carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Synergistic anti-inflammatory effects of low doses of curcumin in combination with polyunsaturated fatty acids: docosahexaenoic acid or eicosapentaenoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Proapoptotic effect of curcumin on human neutrophils: activation of the p38 mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin attenuates DNB-induced murine colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin lowers erlotinib resistance in non-small cell lung carcinoma cells with mutated EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin Induces EGFR Degradation in Lung Adenocarcinoma and Modulates p38 Activation in Intestine: The Versatile Adjuvant for Gefitinib Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Down-regulation of epidermal growth factor receptor by curcumin-induced UBE1L in human bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin inhibits the migration and invasion of mouse hepatoma Hca-F cells through down-regulating caveolin-1 expression and epidermal growth factor receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin Inhibition of the Functional Interaction between Integrin α6β4 and the Epidermal Growth Factor Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21(WAF1/CIP1) and C/EBPbeta expressions and suppressing NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin enhanced antiproliferative effect of mitomycin C in human breast cancer MCF-7 cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin inhibits lung cancer progression and metastasis through induction of FOXO1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-kappaB pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin induces human HT-29 colon adenocarcinoma cell apoptosis by activating p53 and regulating apoptosis-related protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Comparison of oxaliplatin- and curcumin-mediated antiproliferative effects in colorectal cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Upregulation of p53 Expression in Patients with Colorectal Cancer by Administration of Curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin inhibits proliferation and induces apoptosis of leukemic cells expressing wild-type or T315I-BCR-ABL and prolongs survival of mice with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Redox modulation and human bile duct cancer inhibition by curcumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin significantly enhances dual PI3K/Akt and mTOR inhibitor NVP-BEZ235-induced apoptosis in human renal carcinoma Caki cells through down-regulation of p53-dependent Bcl-2 expression and inhibition of Mcl-1 protein stability

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Nutlin-3 inhibits the NFkappaB pathway in a p53-dependent manner: implications in lung cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Induction of apoptosis in human lung cancer cells by curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin induces apoptosis in human colorectal carcinoma (HCT-15) cells by regulating expression of Prp4 and p53

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin enhances the anticancer effects of trichostatin a in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin inhibits SK-Hep-1 hepatocellular carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin: a potential candidate for matrix metalloproteinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin, a potential inhibitor of MMP-2 in human laryngeal squamous carcinoma cells HEp2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and Vascular Endothelial Growth Factor (VEGF).

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin inhibits lung cancer cell migration and invasion through Rac1-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Chemopreventive and chemotherapeutic potential of curcumin in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

The impact of curcumin on breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Nutraceuticals as new treatment approaches for oral cancer--I: Curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Anti-cancer effects of curcumin on head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin and Liver Cancer: A Review

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Dietary factors and pancreatic cancer: The role of food bioactive compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Mechanisms of action of novel agents for prostate cancer chemoprevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Advances in prostate cancer chemoprevention: a translational perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Potential targets for colorectal cancer prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin: a boon to colonic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Molecular mechanisms of chemopreventive phytochemicals against gastroenterological cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

The role of cancer stem cells in the anti-carcinogenicity of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcuma as a functional food in the control of cancer and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

New perspectives of curcumin in cancer prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin in various cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Molecular mechanisms of curcumin action: signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin in Cancer Chemoprevention: Molecular Targets, Pharmacokinetics, Bioavailability, and Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Novel aspects for the application of Curcumin in chemoprevention of various cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Innovative preparation of curcumin for improved oral bioavailability.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

A randomized, placebo-controlled, double-blind clinical trial of curcuminoids in oral lichen planus

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

High-dose curcuminoids are efficacious in the reduction in symptoms and signs of oral lichen planus

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Effect of turmeric oil and turmeric oleoresin on cytogenetic damage in patients suffering from oral submucous fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Dose escalation of a curcuminoid formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Phase II trial of curcumin in patients with advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

The potential role of curcumin in patients with monoclonal gammopathy of undefined significance--its effect on paraproteinemia and the urinary N-telopeptide of type I collagen bone turnover marker

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin and gemcitabine in patients with advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Curcumin treatment suppresses IKKβ kinase activity of salivary cells of patients with head and neck cancer: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Use of curcuminoids in a cohort of patients with oral lichen planus, an autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Effect of imatinib therapy with and without turmeric powder on nitric oxide levels in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES20022728

Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines.

21 January 2018

1 reference

12 December 2020

Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity.

1 reference

12 December 2020

Antitumor, anti-invasion, and antimetastatic effects of curcumin

1 reference

12 December 2020

Curcumin suppresses proliferation and induces apoptosis of human hepatocellular carcinoma cells via the wnt signaling pathway

1 reference

12 December 2020

Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R.

1 reference

12 December 2020

Review. Facts and fiction of phytotherapy for prostate cancer: a critical assessment of preclinical and clinical data

1 reference

12 December 2020

Curcumin (Diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation

1 reference

12 December 2020

Preliminary study on antirheumatic activity of curcumin (diferuloyl methane)

1 reference

12 December 2020

Curcumin: the multi-targeted therapy for cancer regression

1 reference

12 December 2020

Curcuma Contra Cancer? Curcumin and Hodgkin's Lymphoma

1 reference

12 December 2020

The MAPK signaling cascade

1 reference

12 December 2020

Therapeutic potential of curcumin in human prostate cancer. II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein

1 reference

12 December 2020

Extracellular signal-regulated kinase signaling-mediated induction and interaction of FOXO3a and p53 contribute to the inhibition of nasopharyngeal carcinoma cell growth by curcumin

1 reference

12 December 2020

Advances in the treatment of ovarian cancer: a potential role of antiinflammatory phytochemicals

1 reference

12 December 2020

Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions

1 reference

12 December 2020

Curcumin induces heme oxygenase 1 through generation of reactive oxygen species, p38 activation and phosphatase inhibition.

1 reference

12 December 2020

Inhibitory effect of curcumin on motility of human oral squamous carcinoma YD-10B cells via suppression of ERK and NF-kappaB activations

1 reference

12 December 2020

Differentiation and reversal of malignant changes in colon cancer through PPARgamma

1 reference

12 December 2020

Anti-thrombotic effect of curcumin

1 reference

12 December 2020

Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor

1 reference

12 December 2020

Involvement of NF-κB activation in the cisplatin resistance of human epidermoid carcinoma KCP-4 cells

1 reference

12 December 2020

Anti-proliferative potential of curcumin in androgen-dependent prostate cancer cells occurs through modulation of the Wingless signaling pathway

1 reference

12 December 2020

Effect of turmeric on urinary mutagens in smokers

1 reference

12 December 2020

Curcumin suppresses vasculogenic mimicry capacity of hepatocellular carcinoma cells through STAT3 and PI3K/AKT inhibition

1 reference

12 December 2020

Death by design: where curcumin sensitizes drug-resistant tumours

1 reference

12 December 2020

Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cells.

1 reference

12 December 2020

Prevention of ischaemia-induced biochemical changes by curcumin & quinidine in the cat heart

1 reference

12 December 2020

Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma

1 reference

12 December 2020

Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice

1 reference

12 December 2020

Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer.

1 reference

12 December 2020

Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]

1 reference

12 December 2020

p53 and NFkappaB: fresh breath in the cross talk

1 reference

12 December 2020

Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling.

1 reference

12 December 2020

Curcumin treatment alters ERK-1/2 signaling in vitro and inhibits nasopharyngeal carcinoma proliferation in mouse xenografts

1 reference

12 December 2020

Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells.

1 reference

12 December 2020

Synergism from the combination of ulinastatin and curcumin offers greater inhibition against colorectal cancer liver metastases via modulating matrix metalloproteinase-9 and E-cadherin expression

1 reference

12 December 2020

Induction of apoptosis and reduction of MMP gene expression in the U373 cell line by polyphenolics in Aronia melanocarpa and by curcumin

1 reference

12 December 2020

Curcumin inhibits cell cycle progression of immortalized human umbilical vein endothelial (ECV304) cells by up-regulating cyclin-dependent kinase inhibitor, p21WAF1/CIP1, p27KIP1 and p53.

1 reference

12 December 2020

Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer

1 reference

12 December 2020

Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences

1 reference

12 December 2020

A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer

1 reference

12 December 2020

Antihepatotoxic principles of Curcuma longa rhizomes

1 reference

12 December 2020

Curcumin enhances the response of non-Hodgkin's lymphoma cells to ionizing radiation through further induction of cell cycle arrest at the G2/M phase and inhibition of mTOR phosphorylation.

1 reference

12 December 2020

Curcumin suppresses cell proliferation through inhibition of the Wnt/β-catenin signaling pathway in medulloblastoma

1 reference

12 December 2020

The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: analysis of the possible molecular basis.

1 reference

12 December 2020

Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex

1 reference

12 December 2020

Curcumin sensitizes chemotherapeutic drugs via modulation of PKC, telomerase, NF-kappaB and HDAC in breast cancer

1 reference

12 December 2020

Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity

1 reference

12 December 2020

Curcumin protects PC12 cells against 1-methyl-4-phenylpyridinium ion-induced apoptosis by bcl-2-mitochondria-ROS-iNOS pathway

1 reference

12 December 2020

Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-kappaBp65 expression in breast cancer MDA-MB-231 cells.

1 reference

12 December 2020

Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma.

1 reference

12 December 2020

Curcumin-induced cell cycle arrest and apoptosis in human acute promyelocytic leukemia HL-60 cells via MMP changes and caspase-3 activation

1 reference

12 December 2020

Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway

1 reference

12 December 2020

Curcumin induces cell cycle arrest and apoptosis of prostate cancer cells by regulating the expression of IkappaBalpha, c-Jun and androgen receptor

1 reference

12 December 2020

Chemoprevention strategies for pancreatic cancer

1 reference

12 December 2020

Turmeric and curcumin as topical agents in cancer therapy

1 reference

12 December 2020

Nitric oxide scavenging by curcuminoids

1 reference

12 December 2020

Curcumin inhibits LPS-induced EMT through downregulation of NF-κB-Snail signaling in breast cancer cells

1 reference

12 December 2020

Curcumin inhibits cell migration of human colon cancer colo 205 cells through the inhibition of nuclear factor kappa B /p65 and down-regulates cyclooxygenase-2 and matrix metalloproteinase-2 expressions.

1 reference

12 December 2020

Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1

1 reference

12 December 2020

Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy.

1 reference

12 December 2020

Molecular mechanisms of natural products in chemoprevention: induction of cytoprotective enzymes by Nrf2.

1 reference

12 December 2020

Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors.

1 reference

12 December 2020

10.3390/MOLECULES20022728

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665066%20AND%20SRC:MED&resulttype=core&format=json

release_iust2oxcebd57pl4qrjsum5ooe

29 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/iust2oxcebd57pl4qrjsum5ooe

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665066%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

PubMed publication ID

25665066

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665066%20AND%20SRC:MED&resulttype=core&format=json